These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32483835)

  • 81. Heparin-Assisted Amyloidogenesis Uncovered through Molecular Dynamics Simulations.
    Khurshid B; Rehman AU; Luo R; Khan A; Wadood A; Anwar J
    ACS Omega; 2022 May; 7(17):15132-15144. PubMed ID: 35572757
    [TBL] [Abstract][Full Text] [Related]  

  • 82. IL-27 gives a good gut feeling about immune regulation.
    Siniscalco ER; Craft J
    Nat Immunol; 2023 Dec; 24(12):1972-1973. PubMed ID: 37932458
    [No Abstract]   [Full Text] [Related]  

  • 83. VSIG4 interaction with heparan sulfates inhibits VSIG4-complement binding.
    Ebstein SY; Rafique A; Zhou Y; Krasco A; Montalvo-Ortiz W; Yu L; Custodio L; Adam RC; Bloch N; Lee K; Adewale F; Vergata D; Luz A; Coquery S; Daniel B; Ullman E; Franklin MC; Hermann A; Huang T; Olson W; Davis S; Murphy AJ; Sleeman MA; Wei J; Skokos D
    Glycobiology; 2023 Aug; 33(7):591-604. PubMed ID: 37341346
    [TBL] [Abstract][Full Text] [Related]  

  • 84. IL-27 Protects the Brain from Ischemia-Reperfusion Injury via the gp130/STAT3 Signaling Pathway.
    Luo C; Li B; Chen L; Zhao L; Wei Y
    J Mol Neurosci; 2021 Sep; 71(9):1838-1848. PubMed ID: 33851350
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
    Kuschert GS; Coulin F; Power CA; Proudfoot AE; Hubbard RE; Hoogewerf AJ; Wells TN
    Biochemistry; 1999 Sep; 38(39):12959-68. PubMed ID: 10504268
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
    Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
    Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance.
    Clarke D; Katoh O; Gibbs RV; Griffiths SD; Gordon MY
    Cytokine; 1995 May; 7(4):325-30. PubMed ID: 8589262
    [TBL] [Abstract][Full Text] [Related]  

  • 88. SPR Biosensor Probing the Interactions between TIMP-3 and Heparin/GAGs.
    Zhang F; Lee KB; Linhardt RJ
    Biosensors (Basel); 2015 Jul; 5(3):500-12. PubMed ID: 26213979
    [TBL] [Abstract][Full Text] [Related]  

  • 89. IL-12 is a heparin-binding cytokine.
    Hasan M; Najjam S; Gordon MY; Gibbs RV; Rider CC
    J Immunol; 1999 Jan; 162(2):1064-70. PubMed ID: 9916734
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Glycosaminoglycans bind human IL-27 and regulate its activity.
    Cavé MC; Maillard S; Hildenbrand K; Mamelonet C; Feige MJ; Devergne O
    Eur J Immunol; 2020 Oct; 50(10):1484-1499. PubMed ID: 32483835
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells.
    Nader HB; Pinhal MA; Baú EC; Castro RA; Medeiros GF; Chavante SF; Leite EL; Trindade ES; Shinjo SK; Rocha HA; Tersariol IL; Mendes A; Dietrich CP
    Braz J Med Biol Res; 2001 Jun; 34(6):699-709. PubMed ID: 11378657
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Enzymatic synthesis of glycosaminoglycan heparin.
    Linhardt RJ; Dordick JS; Deangelis PL; Liu J
    Semin Thromb Hemost; 2007 Jul; 33(5):453-65. PubMed ID: 17629842
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.